Insights
Insights From Our Experts
Articles
Boosting Pharma Efficiency: A New Model for Asset Value Retention
In the pharmaceutical industry, maintaining asset value is challenging. Traditionally, companies either licensed their products or built their own commercial setup, each option with its own risks. But what if there were a powerful alternative that…
Overcoming the Odds: How EVERSANA Helped a Family Navigate Their Rare Disease Journey
A Rare Diagnosis and the Start of a Family’s Courageous Journey For families navigating the complexities of a rare disease diagnosis, the path can be filled with uncertainty, challenges and moments of profound resilience. One such…
Maximizing Sales with AI: A Strategic Roadmap for Success
Artificial intelligence (AI) is transforming the sales landscape, offering innovative ways to boost efficiency, enhance decision-making and drive revenue growth. With AI adoption in sales ranking among the top three functions across industries, organizations must leverage…
Rare Disease Care in India: A Path to Positive Impact
India’s rare disease market is on the rise, expected to grow from $2.74 billion to $6.6 billion by 2030. However, challenges such as delayed diagnoses, limited treatment accessibility and underutilized government funds continue to impact patient…
Enhancing Medical Strategies Through Effective Literature Surveillance
Posted by
Mary Mehrabian, PharmD, BCGP, BCMAS , Michael DeLuca, PharmD, MBA, MSRA , Varun Pandey, PhD on March 13, 20253/13/25
Members from EVERSANA’s Medical Affairs (MA) team conducted a comprehensive survey to understand the needs of MA professionals regarding literature surveillance, reviews and alerts. They presented their findings at the DIA Medical Affairs and Scientific Communications…
Revolutionizing Customer Experience: The Role of AI in Enhancing MI Contact Center Operations
Posted by
Carolyn Quon, PharmD , Michael DeLuca, PharmD, MBA, MSRA , Varun Pandey, PhD on March 13, 20253/13/25
At the 2025 DIA Medical Affairs and Scientific Communications Forum, experts from EVERSANA gave a presentation on the transformative role of AI in enhancing Medical Information (MI) Contact Center operations and its primary objective – to…
Making Cutting-Edge Cancer Treatments Accessible: Advancing CAR-T Therapy to the Community Practice
Posted by
Anne Marie Robertson , Barry Vucsko , Jordan Schell , Vanitha Sankaran, PhD , Jordan Hayes on March 12, 20253/12/25
This article explores the significant advancements in CAR-T therapy and its transition from academic centers to community practices. CAR-T therapy, a revolutionary treatment for certain hematological malignancies, involves modifying a patient’s T-cells to target and destroy…
The Path to Maximizing Revenue: How to Simplify Pharmaceutical Commercialization and Find Optimum Success
For pharmaceutical manufacturers, achieving optimal revenue in a competitive landscape is a multifaceted challenge that requires strategic foresight and meticulous execution. Small and emerging biotech companies often face significant hurdles in reaching maximum commercial success. In…
Successfully Navigating the Complexity of Market Access Across Europe to Improve Health Equity
Navigating the complexities of bringing new drug therapies to market in Europe is a formidable challenge, especially with the diverse and fragmented reimbursement landscape across the EU’s 27 member states. In this insightful article published in…
Securing Launch Success Within the Context of the New EU Health Technology Assessment Regulation (HTAR) Landscape in Europe
The EU Health Technology Assessment Regulation (HTAR), effective from January 12, 2025, aims to harmonize the evaluation of health technologies across member states to enhance patient access to innovative treatments. In this latest article from Pamela…